|
시장보고서
상품코드
2075849
담낭암 시장 : 치료법별, 암 유형별, 유통 채널별, 지역별Gallbladder Cancer Market, By Treatment Type, By Cancer Type, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
담낭암 시장은 2026년에 8,460만 달러 규모로 추정되며, 2033년까지 1억 1,670만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR 4.7%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 8,460만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) : | 4.70% | 시장 규모 예측(2033년) : | 1억 1,670만 달러 |
담낭암은 비교적 드문 암으로, 고령의 여성에게서 가장 많이 발생합니다. 대부분의 경우, 수술로 담낭을 제거할 수 없게 된 진행 단계에 이르러서야 비로소 발견됩니다. 담낭은 복부 오른쪽, 간 바로 아래에 있는 작은 배 모양의 장기입니다. 담낭은 간에서 생성되는 소화액인 담즙을 저장하는 역할을 합니다. 담낭암의 위험 요인으로는 담석, 담낭 용종, 만성 담낭염, 그리고 특정 유전성 질환 등이 있습니다. 담낭암의 증상으로는 복통(특히 우상복부), 복부 팽만감, 발열, 의도치 않은 체중 감소, 메스꺼움, 피부와 흰자위의 황변(황달) 등이 있습니다.
시장 역학 :
세계의 담낭암 치료 분야 시장은 향후 몇 년 동안 큰 성장을 보일 것으로 전망됩니다. 주로 개발도상국에서 담낭암 발병률이 증가하는 것이 시장 성장의 주요 촉진요인으로 작용하고 있습니다. 또한, 진단 기술과 치료법의 발전으로 환자의 생존율과 삶의 질이 향상되고 있습니다. 예를 들어, 미국 암 협회가 발표한 자료에 따르면, 2023년에는 약 1만 2,220건의 담낭암 신규 사례가 보고되었으며, 그중 남성이 5,750건, 여성이 6,470건이었습니다.
본 조사의 주요 특징 :
- 본 조사에서는 다양한 부문에서 잠재적인 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 세계 담낭암 시장의 주요 기업 프로파일을 소개했습니다.
- 본 조사에서 다룬 주요 기업으로는 일라이 릴리 앤 컴퍼니, 브리스톨-마이어스 스퀴브, 로슈, 화이자, 노바티스, 머크 앤 컴퍼니, 사노피, 아스트라제네카, 애브비, 길리어드 사이언스가 포함됩니다.
- 본 보고서에서 얻을 수 있는 인사이트는 각 기업의 마케팅 담당자 및 경영진이 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략과 관련하여 정보에 기반한 의사결정을 내리는 데 도움이 됩니다.
- 이 책 '세계의 담낭암 시장 보고서'는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 담낭암 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적 및 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 담낭암 시장 : 치료 유형별(2021-2033년)
제5장 담낭암 시장 : 암 유형별(2021-2033년)
제6장 담낭암 시장 : 유통 채널별(2021-2033년)
제7장 담낭암 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
AJY 26.07.09Gallbladder Cancer Market is estimated to be valued at USD 84.6 Mn in 2026 and is expected to reach USD 116.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 84.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.70% | 2033 Value Projection: | USD 116.7 Mn |
Gallbladder cancer is a relatively rare cancer that is most common in older women. It is often discovered at its late stage, when it is no longer possible to remove the gallbladder surgically. The gallbladder is a small, pear-shaped organ on the right side of the abdomen, just beneath the liver. The gallbladder stores bile, a digestive fluid produced by liver. Risk factors for gallbladder cancer include gallstones, gallbladder polyps, chronic gallbladder inflammation, and certain inherited conditions. Symptoms of gallbladder cancer may include abdominal pain, particularly in the upper right portion of the abdomen, abdominal bloating, fever, unintended weight loss, nausea, and yellowing of the skin and the whites of the eyes (jaundice).
Market Dynamics:
The global market for gallbladder cancer treatment is expected to witness significant growth in the coming years. The rising incidence of gallbladder cancer, primarily in developing countries, is a major driver for market growth. Additionally, advancements in diagnostic techniques and treatment modalities are enhancing the survival rates and quality of life for patients. For instance, according to the data published by the American Cancer Society in , about 12,220 new cases of gallbladder cancer : 5,750 in men and 6,470 in women in 2023.
Key features of the study:
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global gallbladder cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Eli Lilly and Company, Bristol-Myers Squibb, Roche, Pfizer, Novartis, Merck & Co., Inc., Sanofi, AstraZeneca, AbbVie, and Gilead Sciences
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global gallbladder cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gallbladder cancer market
Detailed Segmentation:
- By Treatment Type (Revenue, USD Mn, 2021 - 2033)
- Surgery
- Chemotherapy
- Radiation Therapy
- Immunotherapy
- Targeted Therapy
- Others
- By Cancer Type (Revenue, USD Mn, 2021 - 2033)
- Adenocarcinoma
- Squamous cell carcinoma
- Adenosquamous carcinoma
- Small cell carcinoma
- Undifferentiated carcinoma
- Others
- By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Players Operating in Gallbladder Cancer Market
- Eli Lilly and Company
- Bristol-Myers Squibb
- Roche
- Pfizer
- Novartis
- Merck & Co., Inc.
- Sanofi
- AstraZeneca
- AbbVie
- Gilead Sciences
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Gallbladder Cancer Market, By Treatment Type
- Gallbladder Cancer Market, By Cancer Type
- Gallbladder Cancer Market, By Distribution Channel
- Gallbladder Cancer Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing prevalence of gallbladder cancer
- High cost burden of cancer therapies
- Development of targeted therapies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Gallbladder Cancer Market, By Treatment Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Radiation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
5. Gallbladder Cancer Market, By Cancer Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Adenocarcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Squamous cell carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Adenosquamous carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Small cell carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
6. Gallbladder Cancer Market, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
7. Gallbladder Cancer Market, By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2021 - 2033, (US$ Mn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Roche
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AbbVie
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Gilead Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
